Loading…
A. Nelson & Co. Ltd., a UK-based manufacturer of homeopathic drug products, was cited for significant Current Good Manufacturing Practice (CGMP) violations following an FDA inspection in September 2025. The company failed to conduct adequate microbial testing on batches of finished drug products before release, including products labeled for children as young as two years old, and did not perform required testing for total microbial count and objectionable microorganisms on several product lines. Additionally, the firm extended expiration dates for certain homeopathic products without sufficient stability data to support the extended shelf life. These failures rendered the drug products adulterated under the Federal Food, Drug, and Cosmetic Act because the company's manufacturing methods, facilities, and controls did not conform to CGMP regulations.